Pharmaceutical

Q1 2024 update: personalization related M&A activity in the pharmaceutical industry

In the global pharmaceutical industry, there were 2 M&A deals announced in Q1 2024, worth a total value of $418m, according to GlobalData's Deals Database.

May 21, 2024 - 04:00
Q1 2024 update: personalization related M&A activity in the pharmaceutical industry
In the global pharmaceutical industry, there were 2 M&A deals announced in Q1 2024, worth a total value of $418m, according to GlobalData's Deals Database.
Read the original article

Tags:

Previous Article

How future of work private equity performed in the pharmaceutical industry in Q1...

Next Article

Q1 2024 update: individualism & expression related M&A activity in the pharmaceu...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Singapore approves mpox vaccine as it adds border infection checks

Singapore approves mpox vaccine as it adds border infec...

Aug 29, 2024

STAT+: KalVista pill reduces swelling symptoms caused by genetic disease, achieving goal of late-stage study

STAT+: KalVista pill reduces swelling symptoms caused b...

Feb 13, 2024

STAT+: Viking Therapeutics releases early but promising weight loss data on new GLP-1 drug

STAT+: Viking Therapeutics releases early but promising...

Mar 28, 2023